Shares Outstanding for Moderna (MRNA)
According to Moderna's latest reported financial statements, the company's latest reported diluted shares outstanding is 392.00M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
MRNA
Currently viewingShares OutstandingSwitch metric
Latest period
392.00M
YoY change
+1.3%
5Y CAGR
+0.4%
Peak year (2021)
431.00M
Latest annual
389.00M
Shares Outstanding history chart for Moderna (MRNA) from 2016 to 2025
Shares Outstanding history table for Moderna (MRNA) from 2016 to 2025
| Fiscal year | Period ended | Reported | Shares Outstanding | YoY |
|---|---|---|---|---|
| 2025 | 389.00M | +1.3% | ||
| 2024 | 384.00M | +0.5% | ||
| 2023 | 382.00M | -8.2% | ||
| 2022 | 416.00M | -3.5% | ||
| 2021 | 431.00M | +13.0% | ||
| 2020 | 381.33M | +15.3% | ||
| 2019 | 330.80M | +0.6% | ||
| 2018 | 328.80M | -12.6% | ||
| 2017 | 376.00M | +486.6% | ||
| 2016 | 64.09M | — |
Shares Outstanding values are taken from Moderna's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Moderna (MRNA) most recent annual diluted shares outstanding stands at 389.00M (2025) – edged up 1.3% year-over-year.
Moderna diluted shares outstanding compound annual growth for the 2020–2025 (5 years) window is +0.4%, sustaining 2 straight years of year-over-year growth.
Moderna diluted shares outstanding declined from 431.00M in 2021 to 389.00M in 2025, a 9.7% drawdown.
The dataset's maximum diluted shares outstanding sits at 431.00M (2021); the minimum reading of 64.09M dates to 2016.
Among 8 Healthcare peers, Moderna (MRNA) ranks 9th; the peer median for diluted shares outstanding is 1.34B.
Moderna Shares Outstanding by Year
Moderna Shares Outstanding 2025: 389.00M
Moderna diluted shares outstanding in 2025 was 389.00M, edged up 1.3% from 2024.
Moderna Shares Outstanding 2024: 384.00M
Moderna diluted shares outstanding in 2024 was 384.00M, edged up 0.5% from 2023.
Moderna Shares Outstanding 2023: 382.00M
Moderna diluted shares outstanding in 2023 was 382.00M, declined 8.2% below 2022.
Moderna Shares Outstanding 2022: 416.00M
Moderna diluted shares outstanding in 2022 was 416.00M, edged down 3.5% below 2021.
Moderna Shares Outstanding 2021: 431.00M
Moderna diluted shares outstanding in 2021 was 431.00M.
See more financial history for Moderna (MRNA).
Sector peers — Shares Outstanding
Companies in the same sector as Moderna, ranked by their latest diluted shares outstanding.
| Company | Shares Outstanding | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | 4.45B | Healthcare |
| Merck & Co., Inc. (MRK) | 2.51B | Healthcare |
| Johnson & Johnson (JNJ) | 2.43B | Healthcare |
| AbbVie Inc. (ABBV) | 1.77B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | 910.00M | Healthcare |
| Eli Lilly and Company (LLY) | 898.00M | Healthcare |
| AstraZeneca PLC (AZN) | 781.00M | Healthcare |
| Amgen Inc. (AMGN) | 542.00M | Healthcare |
Frequently asked questions
What is Moderna's diluted shares outstanding?
- Latest reported diluted shares outstanding for Moderna (MRNA) is 392.00M (period ending December 31, 2025).
How has Moderna diluted shares outstanding changed year-over-year?
- Moderna (MRNA) diluted shares outstanding changed +1.3% year-over-year on the latest annual filing.
What is the long-term growth rate of Moderna diluted shares outstanding?
- Moderna (MRNA) diluted shares outstanding compound annual growth rate is +0.4% over the most recent 5 years available.
When did Moderna diluted shares outstanding hit its highest annual value?
- Moderna diluted shares outstanding reached its highest annual value of 431.00M in 2021.
What was Moderna diluted shares outstanding in 2024?
- Moderna (MRNA) diluted shares outstanding in 2024 was 384.00M.
What was Moderna diluted shares outstanding in 2025?
- Moderna (MRNA) diluted shares outstanding in 2025 was 389.00M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
MRNA Overview
Company profile, financial tools, and key metrics
MRNA Revenue Counter
Earns $61.61 every second. See per minute, hour, and day.
MRNA Earnings Counter
Loses −$89.49 per second. See per minute, hour, and day.
MRNA Economic Scale
Exceeds Timor-Leste's GDP. Compare with world economies.
MRNA What If Invested
What if you had invested $1,000? See historical returns from any date.
MRNA How It Makes Money
Discover visual breakdown of $1.94B in revenue — where it comes from and where it goes.
MRNA Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
MRNA Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
MRNA Daily Price Character
Explosive · 48.2% historical win rate (green days). Streaks & record days.
MRNA Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.